Tissue Regenix Share Discussion Threads

[the stigologist] 21/1/2020 11:50

10p that's my target

10p is what the big cheese here paid

[theapplefreak] 21/1/2020 11:41

Thats why we have continued uptrend.....
Buyers know what they are buying.
The only people selling out are the day traders making their 10% and moving on.

Everyone else is here for the lift off. First stop 2p, then 3,4,5 then who knows.

[iamgreat1] 21/1/2020 11:34

Placing Rns soon upon those

[monster500] 21/1/2020 11:32

Looking really good today. I think the message is finally getting through that the company has a bright future. I personally do, onwards and upwards:)

[theapplefreak] 21/1/2020 11:26

Nice buying starting up again to tick the bid up to 1.70 once again.
Along with a code 1 buy, make what you will with that.
dyor etc.

[iamgreat1] 21/1/2020 11:09

Was under 1p and will soon be under 1p

[iamgreat1] 21/1/2020 11:08

Stig you were impaled with PYC at 30p pmslNow this dog trx is nothing but pure rampSoon placing will be delivered at 1pThe placees are selling out now and dummies buying

[the stigologist] 21/1/2020 11:00

John Samuel

bought 2 million at 10p a couple of years back

That tells you Management aligned with shareholders

[theapplefreak] 21/1/2020 10:58

Just buy in iamediocre, would be hard pressed to get a better price than its current standing.
All your deramping since it started to rise has been to no avail.
Think of all the cash youd have now if you just bought instead of talking bs.

[the stigologist] 21/1/2020 10:53

OK overhang been issue since around 6p in June 2019 as far as I can tell

channel pirate - 11 Jun 2019 - 10:35:12 - 2088 of 5388 Tissue Regenix delivering practical solutions to real clinical issues - TRX

Anyone else think that these frequent 50,000 share sells dumped early some mornings might be Mr Woodford having to liquidize his holding in order to keep his funds afloat ?

[iamgreat1] 21/1/2020 10:49

People always blame "the overhang" This will spiral back to 1p soon

[iamgreat1] 21/1/2020 10:48

Not a single piece of confirmed news from the company since last November So most of this is sheer ramping from the same gangs that operate around here and twitter

[the stigologist] 21/1/2020 10:48

Overhang has been major issue forcing it down from 10p?

Don't see why we should't see bounce to 5p if/when overhang pressure released

[ileeman] 21/1/2020 10:28

Started buying.

Hard to ignore the chart, breaking major resistance levels at 1.6-1.7p.

[theapplefreak] 21/1/2020 10:21

They'll take 1m shares at 1.70 from me on HL.
Someone is on the hunt!
EDIT: Now NT..

[theapplefreak] 21/1/2020 10:17

Looks like strong buying above 1.60 now.
As I type we've ticked up over 1.65 on the bid and could hit 1.70 any moment is the momentum continues.
EDIT: 1.70 just been paid.
Time to rise ladies.

[bull sykes] 21/1/2020 09:45

I don't know about John Samuel, but I am feeling that TRX is exposed to a bid or two soon, especially if a great Q4 result is announced first week in Feb. (Q4 figures last year released 04.02.2019).
He might want to load up with debt (a loan has been agreed and company will need money at end of Q1), to make TRX less attractive,
again he might not if the intention is to find a buyer at this stage in TRX development.
I am hoping TRX can find a lender that offers a better rate, as I'm not sure LIBOR + 6.75% is very competitive.


enteleon, - ref your previous post.
All board members bar one are qualified and experienced financial men.
Seems to me the last CFO (who has worked with TRX before) quit after two months because there were too many cooks in the kitchen.

For further research try the ARMS medical website, and www.2swell.com/leadershipteam, - Michel Koopman.

[enteleon] 20/1/2020 22:49

As a retired medic with a degree in medical physics, I have been intrigued by TRX for some time. TRX's platform of products is deeply impressive. My anxieties have centred largely on the difficult time the Board has experienced with the long term illness, then retirement (1st August, 2019), of Steve Couldwell and the very short tenure by Mike Barker of the post of CFO (appointed 28th August, 2019; resigned November, 2019). Kirsten Lund, the current Group Finance Director, does not sit on the Board.

This leaves the Executive Chairman, John Samuel, as the major leading light. His history is, however, significant. He was CEO of Molnlycke Health Care Group, building up this corporation to a buyout by Investor AB and Morgan Stanley Principal Investments for 2.85 Billion Euro in March, 2007. Molnlycke developed single-use surgical and wound care products, so his prior experience is very aligned with that of TRX.

My impression is that Samuel has taken a very firm grip of the tiller and he has been Chairman of TRX for nearly twelve years (appointed April, 2008, not long after the highly successful buyout of Molnlycke). I detect his fingerprints all over the revised loan agreements announced by RNS on November 11th and 14th, particularly the latter.

Having paid back the $5.5M of Tranche One, MidCap has added this to its Tranche Two of $5M, thus amounting to a $10.5M future facility. The Tranche Three future facility of $2.5M remains in place. The Term Loan of $2M (Tranche One) will be repaid beginning on July 1st, 2020 across 48 months. Quoting from the November 14th RNS: "the drawdown of these tranches (Two and Three) is now subject to MidCap's discretion and satisfactory recapitalisation of the Company at that time."

We cannot know exactly what Samuel's strategy is, but his options are open. With his prior contacts, he may approach another lender at more favourable rates (TRX are currently paying US LIBOR + 6.75%); he may choose an equity placing or a rights issue. Whatever, I sense that Samuel has the bit between his teeth and, with an impressive reputation to maintain, will do his utmost to maximise the potential of this very promising Company.

Very best of luck everybody !

[32sam] 20/1/2020 20:49

I wish some folk understand difference between a company needing cash flow as opposed to one that is without any assets or products and cannot raise money. This company has advanced biotech products which are needed and once demand increases, I hope it becomes one of leading bioscience companies but on the other could be swallowed by one of the big pharmas but not before we get a value of 30p!GA

[traderguy1] 20/1/2020 18:45

Haha Graham. Nice try, you really don’t have a clue. Not even worth trying to explain. Go trade another stock simples, we don’t care for yr input here...lol